The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: -106.00 (-0.87%)
Spread: 2.00 (0.017%)
Open: 12,092.00
High: 12,178.00
Low: 12,010.00
Prev. Close: 12,156.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

GLOBAL MARKETS-Stocks fall as virus worries weigh; U.S. dollar near flat

Mon, 04th Jan 2021 16:45

* U.S. stocks lower in early New York trading

* Gold prices rally

* U.S. bond prices fall
(Updates with early U.S. markets; changes dateline; previous
LONDON)

By Caroline Valetkevitch

NEW YORK, Jan 4 (Reuters) - A global stock index fell on
Monday, the first trading day of the new year, pulling back
after recent gains to record highs, and the U.S. dollar was near
flat.

U.S. stocks were down sharply by late morning in New York,
with the S&P 500 nearly 1.4% lower.

Stocks hit records early in the session as investors focused
on the rollout of COVID-19 vaccines.

But investors quickly turned cautious over the path of the
virus, which continues to spread amid the discovery of a new
variant.

The outcome of runoff elections on Tuesday in Georgia for
two U.S. Senate seats added to investor nervousness.

"It's a small reversal, but I think people came in the
morning to start the year with some optimism, but the cloudy
political picture in the U.S. is weighing down the markets a
little bit," said Rick Meckler, partner at Cherry Lane
Investments in New Vernon, New Jersey.

MSCI's All-Country World Index, which tracks
stocks across 49 countries, was down 0.6% after earlier hitting
a record high.

The Dow Jones Industrial Average fell 535.35 points,
or 1.75%, to 30,071.13, the S&P 500 lost 59.08 points, or
1.57%, to 3,696.99 and the Nasdaq Composite dropped
183.74 points, or 1.43%, to 12,704.55.

The pan-European STOXX 600 index rose 0.687%, while
Britain's FTSE 100 index was up 1.7% on its first
post-Brexit trading day.

Britain began vaccinating its population with the COVID-19
shot developed by Oxford University and AstraZeneca on
Monday.

With the lag between a full vaccine rollout and a global
economic recovery, investors will count on central banks to keep
money cheap.

Minutes of the Federal Reserve's December meeting are due on
Wednesday and should offer more detail on discussions about
making the Fed's forward policy guidance more explicit and the
chance of a further increase in asset buying this year.

Friday brings the U.S. December payroll report.

In currencies, the U.S. dollar recovered after falling to
its lowest level since April 2018.

The dollar index rose 0.088%, with the euro up
1.03% to $1.2262.

The Japanese yen strengthened 0.03% versus the greenback at
103.17 per dollar, while Sterling was last trading at
$1.3561, down 0.80% on the day.

Gold prices were up more than 2%, U.S. crude futures
and Brent futures were lower.

Benchmark 10-year Treasury notes last fell 4/32
in price to yield 0.9248%.

(Additional reporting by Ritvik Carvalho in London and by Medha
Singh and Shivani Kumaresan in Bengaluru; Editing by Toby Chopra
and Dan Grebler)

More News
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

Read more
3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsortix technology, opening the door for future clinical study-supporting contracts.

Read more
3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out of hawkish Federal Reserve interest rate expectations.

Read more
2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.

Read more
29 Apr 2024 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe and Asia at the start of the new week.

Read more
29 Apr 2024 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.

Read more
26 Apr 2024 09:33

LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
25 Apr 2024 16:57

LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge

(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump for miner Anglo American after it received a takeover bid from peer BHP.

Read more
25 Apr 2024 15:14

London close: Stocks finish mixed as US GDP growth slows

(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth reading from the United States, while a slew of well-received earnings underpinned the top-flight index.

Read more
25 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 hits high on offer for Anglo American

(Alliance News) - The FTSE 100 was outperforming European markets at midday on Thursday, with the index boosted to a record high thanks to takeover talks.

Read more
25 Apr 2024 10:33

AstraZeneca leaps after smashing first-quarter forecasts

Q1 revenue up 19% to $12.68 bln

*

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.